New Parkinson's drug could slow or reverse progression of disease, researchers say: 'Big step forward'
Fox News
A new therapeutic that could slow down or halt the progression of Parkinson's disease has completed Phase 1 trials with positive results. Researchers and doctors spoke about the findings.
"Time and science will help us to determine if this newer approach will fare better." Angelica Stabile is a lifestyle writer for Fox News Digital.
Researchers conducted a phase 1 placebo-controlled trial of an investigational immunotherapy drug called UB-312, testing for safety, tolerability and immunogenicity (strength of immune response).
More Related News